Showing results (1781-1790 of 2,702) with videos related to

Sort By:
Pageof 271
Nature Communications|June 26, 2024
Structure of an RNA G-quadruplex from the West Nile virus genomeJ Ross Terrell, Thao T Le, Ananya Paul, et al.
Therapeutic Advances in Cardiovascular Disease|February 28, 2016
Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulationStacey Knight, Raymond O McCubrey, Zhong Yuan, et al.
Epilepsy Research|June 28, 2019
Synthetic aperture magnetometry and excess kurtosis mapping of Magnetoencephalography (MEG) is predictive of epilepsy surgical outcome in a large pediatric cohortJ S Gofshteyn, T Le, S Kessler, et al.
Nucleic Acids Research|May 26, 2018
Nucleoside analogs to manage sequence divergence in nucleic acid amplification and SNP detectionZunyi Yang, Hyo-Joong Kim, Jennifer T Le, et al.
Plos One|October 30, 2014
IL22 regulates human urothelial cell sensory and innate functions through modulation of the acetylcholine response, immunoregulatory cytokines and antimicrobial peptides: assessment of an in vitro modelPhong T Le, Meghan M Pearce, Shubin Zhang, et al.
Lancet (London, England)|August 25, 2001
Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective studyT R Navin, C B Beard, L Huang, et al.
The Analyst|March 12, 2020
Rapid, quantitative therapeutic screening for Alzheimer's enzymes enabled by optimal signal transduction with transistorsSon T Le, Michelle A Morris, Antonio Cardone, et al.
Annals of Plastic Surgery|February 8, 2019
Traumatic Falls in the Pediatric Population: Facial Fracture Patterns Observed in a Leading Cause of Childhood InjuryNicholas C Oleck, Andrew A Dobitsch, Farrah C Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2005
Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationshipsD E Keyler, S A Roiko, E Benlhabib, et al.
British Journal of Cancer|June 1, 1994
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancerJ L Pujol, A Monnier, J Berille, et al.
Pageof 271